These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 33597443)

  • 1. Immunogenic and antigenic heterogeneity of Blastocystis sp. subtype 3 from symptomatic and asymptomatic individuals.
    Sheela Devi S; Suresh K
    Trop Biomed; 2019 Mar; 36(1):234-244. PubMed ID: 33597443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope variances demonstrated by Blastocystis sp. ST3 symptomatic and asymptomatic isolates.
    Sheela DS; Chandramathi S; Suresh K
    Trop Biomed; 2020 Mar; 37(1):210-217. PubMed ID: 33612732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic variation in Blastocystis sp. ST3.
    Ragavan ND; Govind SK; Chye TT; Mahadeva S
    Parasit Vectors; 2014 Aug; 7():404. PubMed ID: 25174569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Phenotypic Variation of
    Rajamanikam A; Hooi HS; Kudva M; Samudi C; Govind SK
    Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009838
    [No Abstract]   [Full Text] [Related]  

  • 5. The role and influence of bacteria on the growth of Blastocystis sp. subtype 3.
    Kaur CP; Yong CC; Rajamanikam A; Samudi C; Kumar S; Bhassu S; Mohamad S; Venugopal K; Kareem SA
    Parasitol Res; 2023 Jul; 122(7):1463-1474. PubMed ID: 37162590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity analysis of Blastocystis subtypes from both symptomatic and asymptomatic subjects using a barcoding region from the 18S rRNA gene.
    Rezaei Riabi T; Mirjalali H; Haghighi A; Rostami Nejad M; Pourhoseingholi MA; Poirier P; Delbac F; Wawrzyniak I; Zali MR
    Infect Genet Evol; 2018 Jul; 61():119-126. PubMed ID: 29608961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment.
    Raman K; Kumar S; Chye TT
    Parasitol Res; 2016 Jan; 115(1):391-6. PubMed ID: 26481491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtyping of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Makkah, Saudi Arabia.
    Mohamed RT; El-Bali MA; Mohamed AA; Abdel-Fatah MA; El-Malky MA; Mowafy NM; Zaghlool DA; Bakri RA; Al-Harthi SA
    Parasit Vectors; 2017 Apr; 10(1):174. PubMed ID: 28388938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients.
    Franklin F; Rajamanikam A; Raju CS; Gill JS; Francis B; Sy-Cherng LW; Kumar S
    Parasit Vectors; 2022 Sep; 15(1):313. PubMed ID: 36064639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Study of Phenotypic and Growth Rate Features of
    Karamati SA; Mirjalali H; Niyyati M; Rezaei Riabi T; Yadegar A; Asadzadeh Aghdaei H; Haghighi A; Seyyed Tabaei SJ; Zali MR
    Iran J Parasitol; 2019; 14(2):204-213. PubMed ID: 31543908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype analysis of Blastocystis sp. isolates from asymptomatic individuals in an urban community in the Philippines.
    Adao DE; Dela Serna AO; Belleza ML; Bolo NR; Rivera WL
    Ann Parasitol; 2016 Oct; 62(3):193–200. PubMed ID: 27770759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface ultrastructure, protein profile and zymography of
    Ahmed MM; Habib FSM; Saad GA; El Naggar HM
    J Parasit Dis; 2019 Jun; 43(2):294-303. PubMed ID: 31263336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Caspase-like activity in symptomatic isolates of Blastocystis spp.
    Balakrishnan DD; Kumar SG
    Parasit Vectors; 2014 May; 7():219. PubMed ID: 24886677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut bacteria influence Blastocystis sp. phenotypes and may trigger pathogenicity.
    Rajamanikam A; Isa MNM; Samudi C; Devaraj S; Govind SK
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011170. PubMed ID: 36989208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in clinical significance and morphologic features of Blastocystis sp subtype 3.
    Vassalos CM; Spanakos G; Vassalou E; Papadopoulou C; Vakalis N
    Am J Clin Pathol; 2010 Feb; 133(2):251-8. PubMed ID: 20093234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprotozoal potential of
    El-Bali MA; Abdulhakim A; Mohamed RT; El-Malky MA; Bakri RA; Al-Harthi SA
    J Parasit Dis; 2020 Dec; 44(4):694-701. PubMed ID: 33184536
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France.
    El Safadi D; Cian A; Nourrisson C; Pereira B; Morelle C; Bastien P; Bellanger AP; Botterel F; Candolfi E; Desoubeaux G; Lachaud L; Morio F; Pomares C; Rabodonirina M; Wawrzyniak I; Delbac F; Gantois N; Certad G; Delhaes L; Poirier P; Viscogliosi E
    BMC Infect Dis; 2016 Aug; 16(1):451. PubMed ID: 27566417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence.
    Rajamanikam A; Hooi HS; Kudva M; Samudi C; Kumar S
    PLoS One; 2019; 14(2):e0212542. PubMed ID: 30794628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.
    Girish S; Kumar S; Aminudin N
    Parasit Vectors; 2015 Jun; 8():332. PubMed ID: 26082155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of microRNAs and claudin-7 in Caco-2 cell line treated with Blastocystis sp., subtype 3 soluble total antigen.
    Mohammad Rahimi H; Yadegar A; Asadzadeh Aghdaei H; Mirjalali H; Zali MR
    BMC Microbiol; 2022 Apr; 22(1):111. PubMed ID: 35459091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.